File #: 19-840    Version: 1 Name:
Type: Zoning Item Status: Consent Agenda
File created: 5/31/2019 In control: Planning and Building
On agenda: 6/6/2019 Final action: 6/6/2019
Title: Hogwash Pharms, Special Permit Application Number: 11377 Case Number: SP16-215 Assessor's Parcel Numbers: (APNs): 220-292-012 and 220-292-013 4505 Slide Creek Road, Whitethorn area Project Description: A Special Permit for the continued operation of an existing cannabis cultivation site consisting of 10,000 square feet of existing outdoor cannabis cultivation. Water for irrigation is sourced from rain catchment and from an existing well located on an adjacent parcel (APN 220-292-013) with the same owner The project includes a Special Permit for encroachment into a Streamside Management Area to perform restoration activities associated with the decommissioning of a portion of a greenhouse.
Attachments: 1. SP-16-215 Staff Report.pdf

Title

Hogwash Pharms, Special Permit

                                  Application Number: 11377

                                  Case Number: SP16-215

                                  Assessor’s Parcel Numbers: (APNs): 220-292-012 and 220-292-013

 4505 Slide Creek Road, Whitethorn area

 

Project Description: A Special Permit for the continued operation of an existing cannabis cultivation site consisting of 10,000 square feet of existing outdoor cannabis cultivation. Water for irrigation is sourced from rain catchment and from an existing well located on an adjacent parcel (APN 220-292-013) with the same owner The project includes a Special Permit for encroachment into a Streamside Management Area to perform restoration activities associated with the decommissioning of a portion of a greenhouse.

Recommendation

Find that the Zoning Administrator has considered the Addendum to the Mitigated Negative Declaration adopted for the Commercial Medical Marijuana Land Use Ordinance, make all of the required findings for approval of the Special Permits based on evidence in the staff report and adopt the Resolution approving the proposed Hogwash Pharms  Special Permit subject to the recommended conditions